Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

被引:0
|
作者
Korb, M. [1 ]
Peck, A. [2 ]
Berger, K. [3 ]
James, M. [4 ]
Ghoshal, N. [5 ]
Healzer, E. [6 ]
Henchcliffe, C. [1 ]
Khan, S. [7 ]
Mammen, P. [7 ]
Patel, S. [8 ]
Pfeffer, G. [9 ]
Ralston, S. [10 ]
Roy, B. [11 ]
Seeley, B. [12 ]
Swenson, A. [13 ]
Mozaffar, T. [1 ]
Weihl, C. [5 ]
Kimonis, V. [1 ]
Alfano, L. [14 ]
机构
[1] UC Irvine Sch Med, Orange, CA USA
[2] Cure VCP Dis, Americus, GA USA
[3] NYU, Grossman Sch Med, New York, NY USA
[4] John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[5] Washington Univ, St Louis, MO 63110 USA
[6] Thriving Hope Consulting, Vinton, VA USA
[7] UT Southwestern Sch Med, Dallas, TX USA
[8] Wellness Sujata, Wadsworth, OH USA
[9] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[10] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[11] Yale Sch Med, New Haven, CT USA
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[14] Nationwide Childrens Hosp, Columbus, OH USA
关键词
D O I
10.1016/j.nmd.2021.07.372
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP.347
引用
收藏
页码:S155 / S156
页数:2
相关论文
共 50 条
  • [31] Valosin-containing protein: A potential therapeutic target for cardiovascular diseases
    Rakhe, Nameerah
    Bhatt, Lokesh Kumar
    AGEING RESEARCH REVIEWS, 2024, 101
  • [32] VALOSIN-CONTAINING PROTEIN, VCP, IS A UBIQUITOUS CLATHRIN-BINDING PROTEIN
    PLEASURE, IT
    BLACK, MM
    KEEN, JH
    NATURE, 1993, 365 (6445) : 459 - 462
  • [33] Pancreatic Toxicity of Valosin-Containing Protein (VCP) Inhibitors in Rodents
    Wolenski, F. S.
    Enos, K.
    Gavin, J.
    Harrison, S.
    Berger, A.
    Gould, S.
    Mallender, W.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (01) : 70 - 71
  • [34] Phenotypic variability in three families with valosin-containing protein mutation
    Spina, S.
    Van Laar, A. D.
    Murrell, J. R.
    Hamilton, R. L.
    Kofler, J. K.
    Epperson, F.
    Farlow, M. R.
    Lopez, O. L.
    Quinlan, J.
    DeKosky, S. T.
    Ghetti, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) : 251 - +
  • [35] Valosin-containing protein gene mutations -: Clinical and neuropathologic features
    Guyant-Marechal, L.
    Laquerriere, A.
    Duyckaerts, C.
    Dumanchin, C.
    Bou, J.
    Dugny, F.
    Le Ber, I.
    Frebourg, T.
    Hannequin, D.
    Campion, D.
    NEUROLOGY, 2006, 67 (04) : 644 - 651
  • [36] Expression and characterization of a new valosin-containing protein from silkworm
    Chen, Ping
    Wang, Ruo-Ran
    Peng, Zhen
    Liu, Qiong
    Ni, Jia-Zuan
    INSECT SCIENCE, 2012, 19 (05) : 549 - 558
  • [37] Antitumor activity of xanthohumol, an inhibitor of valosin-containing protein.
    Shikata, Yuki
    Kanagaki, Shuhei
    Sasazawa, Yukiko
    Tashiro, Etsu
    Yoshimaru, Tetsuro
    Komatsu, Masato
    Katagiri, Toyomasa
    Imoto, Masaya
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] The Valosin-Containing Protein Provides a Novel Mechanism of Preconditioning in vivo
    Lizano, Paulo
    Rashed, Eman
    Depre, Christophe
    Qiu, Hongyu
    CIRCULATION, 2011, 124 (21)
  • [39] High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma
    Cui, Yan
    Niu, Ming
    Zhang, Xianyu
    Zhong, Zhenbin
    Wang, Ji
    Pang, Da
    TUMOR BIOLOGY, 2015, 36 (12) : 9919 - 9927
  • [40] Valosin-containing protein gene mutations: Clinical and histopathologic features in a series of 16 patients
    Stojkovic, T.
    Hammouda, E.
    Richard, P.
    Lopez de Munain, A.
    Pnisson-Besnier, I.
    Ferrer, X.
    Lacour, A. .
    Bassez, G.
    Lacomblez, I.
    Lacene, E.
    Eymard, B.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 850 - 850